WorksheetsKnowledge Fitness Adv Wc Jan-26
Total questions: 60
Worksheet time: 43mins
Name
Class
Date
1.
When are systemic antibiotics indicated in DFU?
a)
When at least 1 of the 5 clinical signs of infection are diagnosable.
b)
When at least 2 of the 5 clinical signs of infection are diagnosable.
c)
When at least 3 of the 5 clinical signs of infection are diagnosable.
d)
When all 5 clinical signs of infection are diagnosable.
2.
What conditions can mask the clinical signs of infection in diabetic foot ulcers
a)
Neuropathy and peripheral arterial disease
b)
Hypertension and diabetes
c)
Obesity and high cholesterol
d)
Asthma and COPD
3.
What is a potential consequence of prescribing systemic antibiotics when not indicated?
a)
Increased wound healing
b)
Antimicrobial resistance
c)
Reduced pain
d)
Improved blood circulation
4.
What is the primary purpose of initial wound cleansing?
a)
To remove loose devitalized tissue, microorganisms, or debris from the wound bed
b)
To apply a barrier cream
c)
To hydrate the skin
d)
To debride the wound
5.
Which of the following is appropriate for cleansing noninfected wounds?
a)
Antiseptic solution
b)
Sterile normal saline
c)
Hydrogen peroxide
d)
Alcohol
6.
What percentage of chronic non-healing wounds are estimated to be affected by biofilm?
a)
0.5
b)
0.6
c)
0.8
d)
0.9
7.
How often are debridement sessions recommended to disrupt biofilm defenses?
a)
Once a week
b)
Twice a week
c)
Once a month
d)
Daily
8.
What is a key advantage of Sorbact's mode of action?
a)
It has no side effects or limitations
b)
It requires frequent application
c)
It is more expensive
d)
It releases antibiotics into the wound
9.
When is systemic antibiotic treatment justified for a diabetic foot ulcer infection?
a)
When the patient requests it
b)
Only when an infection is clearly diagnosed
c)
For all diabetic foot ulcers
d)
When there is mild swelling
10.
Which clinical signs indicate a mild diabetic foot ulcer infection?
a)
Local swelling and erythema
b)
Purulent discharge and pain
c)
Localized increased warmth
d)
At least two of the above signs
11.
How long should systemic antibiotics be given for a mild diabetic foot ulcer infection?
a)
1 to 2 days
b)
1 to 2 weeks
c)
3 to 4 days
d)
3 to 4 weeks
12.
When should the duration of systemic antibiotic treatment be extended to 3 or 4 weeks?
a)
If the infection resolves quickly
b)
If the patient has no other health issues
c)
If the infection improves but is extensive and resolves more slowly than expected
d)
If the patient requests it
13.
What percentage of patients with diabetic foot ulcers have severe peripheral arterial disease (PAD)?
a)
0.22
b)
0.33
c)
0.44
d)
0.55
14.
Why does Sorbact offer a competitive advantage in the treatment of diabetic foot ulcer infections?
a)
It is cheaper than other dressings
b)
It has no cytotoxic effect on cell growth in the wound
c)
It requires fewer dressing changes
d)
It contains antibiotics
15.
Which factor can lead to high levels of exudate ?
a)
Increased bacterial load
b)
Dehydration
c)
Ischemia
d)
Delayed remodeling
16.
Which type of silver dressing is used in Aquacel Ag+ Extra?
a)
Nanocrystalline silver
b)
Nanocrystalline silver plus EDTA and BeCl
c)
Foam dressing with or without foam
d)
Wound contact layer
17.
What is the maximum recommended treatment duration for Mepilex Ag?
a)
Up to 7 days
b)
Up to 4 weeks
c)
1 month
d)
14 days
18.
What are the two main benefits of the bacterial-binding dressings mentioned in the Chadwick review?
a)
Reduce levels of bioburden and promote healing in static/chronic wounds.
b)
Increase wound exudate and reduce inflammation.
c)
Provide pain relief and reduce scarring.
d)
Enhance blood circulation and prevent infection.
19.
How do hydrophobic interactions contribute to microbial infection according to the Doyle's review?
a)
By enhancing the nutritional uptake of pathogens.
b)
By facilitating the adhesion of pathogens to host tissues.
c)
By increasing the metabolic rate of microbes.
d)
By reducing the immune response of the host.
20.
Against which pathogens was the antimicrobial activity of the DACC-coated dressing evaluated in Husmark's study?
a)
Common skin flora
b)
WHO-prioritised wound pathogens
c)
Environmental bacteria
d)
Gut microbiota
21.
What type of study design was used in the research by G. Mosti et al.?
a)
Observational study
b)
Randomised comparative single centre study
c)
Case-control study
d)
Cohort study
22.
Which dressing was found to be significantly more effective in reducing bacterial burden in Mosti et al.?
a)
Silver-containing hydrofiber (SCH) dressing
b)
Microorganism-binding (MB) Sorbact dressing
c)
Both were equally effective
d)
Neither was effective
23.
What is a significant advantage of Sorbact in treating wounds with prioritized pathogens like MRSA, VRE, and ESBL?
a)
It neutralizes all pathogens instantly
b)
It binds strongly to these pathogens over an extended time
c)
It releases antibiotics to kill these pathogens
d)
It changes the pH of the wound environment
24.
Sorbact's mode of action is purely physical. It does not release active agents into the wound.
a)
True
b)
False
25.
Sorbact can promote the development of antimicrobial resistance
a)
True
b)
False
26.
What is the primary aim of Ron J. Doyle's review on the hydrophobic effect in microbial infection?
a)
To study the genetic makeup of pathogens.
b)
To explore the role of hydrophobic interactions in microbial adhesion and infection.
c)
To analyze the nutritional requirements of microbes.
d)
To investigate the environmental impact of microbial infections.
27.
What was the average bacterial load reduction in the SCH (Silver) group in Mosti et al.?
a)
0.731
b)
0.416
c)
0.5
d)
0.9
28.
What does biofilm protect bacteria from?
a)
Antibiotics
b)
Antiseptics
c)
The body's immune system
d)
All of the above
29.
What makes Sorbact unique in its action?
a)
It releases antibiotics into the wound
b)
It binds bacteria physically without cytotoxic effects
c)
It changes color when in contact with bacteria
d)
It provides a cooling effect on the wound
30.
What was the average bacterial load reduction in the Microorganism-binding (MB) Sorbact dressing group in Mosti et al.?
a)
0.731
b)
0.416
c)
0.5
d)
0.9
31.
How does biofilm affect wound healing?
a)
It speeds up wound healing
b)
It delays wound healing
c)
It has no effect on wound healing
d)
It only affects infected wounds
32.
What is Sorbact's role in the management of biofilm?
a)
It acts as an antibiotic
b)
It binds bacteria in the presence of biofilm
c)
It provides hydration to the wound
d)
It acts as an antiseptic
33.
What is a key advantage of Sorbact compared to other topical dressings?
a)
It has a cytotoxic effect on cell growth
b)
It allows for prolonged treatment without any cytotoxic effect on cell growth
c)
It requires less frequent application
d)
It is more expensive
34.
What reduces the effect of Sorbact on wound healing?
a)
Inadequate wound cleansing, debridement, and peri wound skin care
b)
Excessive use of antibiotics
c)
Overhydration of the wound
d)
Frequent dressing changes
35.
You are explaining to a Doctor how Cutimed Sorbact works. Which of the following statements you should include?
a)
"Cutimed Sorbact releases antibiotics to kill bacteria."
b)
"Cutimed Sorbact has a hydrophilic surface that attracts moisture."
c)
"Cutimed Sorbact has a special coating that binds bacteria and endotoxins."
d)
"Cutimed Sorbact increases blood flow to the wound area."
36.
The Cutimed Siltec heel comes in a bordered and non-bordered variant
a)
True
b)
False
37.
What is osteomyelitis ?
a)
Cellulitis
b)
Infection of the tendon
c)
Infection of the bone
d)
Surgical site infection
38.
A green tinge in the wound tissue could be an indication of what type of bacterial infection?
a)
Staphylococcus
b)
Pseudomonas
c)
Streptococcus
d)
MRSA
39.
What is the primary benefit of using Sorbact dressings in diabetic foot ulcer infections?
a)
Enhances systemic antibiotic delivery
b)
Reduces bioburden at the wound site
c)
Increases blood flow to the affected area
d)
Provides nutritional support to the tissue
40.
What is the benefit of debridement in wound care?
a)
It permanently removes biofilm and does not allow to reoccurence
b)
It provides a window of opportunity in which biofilm defenses are temporarily disrupted
c)
It hydrates the wound bed
d)
It applies a barrier cream
41.
What is the primary focus of Johanna Husmark's in vitro study on DACC-coated wound dressings?
a)
To compare different types of wound dressings.
b)
To evaluate the antimicrobial effects of DACC-coated dressings.
c)
To analyze the cost-effectiveness of wound treatments.
d)
To investigate the side effects of antimicrobial agents.
42.
Which of the following is NOT listed as a clinical sign of infection in DFU?
a)
Local swelling
b)
Erythema
c)
Dizziness
d)
Purulent discharge
43.
What is a key risk for a patient with a diabetes related foot ulcer?
a)
Osteomyelitis
b)
Malnutrition
c)
High blood pressure
d)
Congestive heart failure
44.
What is the definition of a chronic wound?
a)
A wound that does not heal within 6 weeks
b)
A wound that does not heal
c)
A wound that does not heal in an orderly manner within the expected time frame
d)
A wound that heals by secondary intention
45.
How many clinical studies were included in the Paul Chadwick review?
a)
15
b)
29
c)
50
d)
49
46.
How does Sorbact contribute to Antimicrobial Stewardship
a)
Sorbact can be used at all stages in the infection continuum to controll bacteria and has no limitation in treatment time.
b)
There is no release of active substances to the wound and antimicrobial resistance is therefor not expected
c)
By always replacing all antibiotic use to treat a wound infection with Sorbact
d)
Sorbact may reduce the use of antibiotics
e)
Antimicrobial Stewardship does only concern less use of anitbiotics and Sorbact is therefore not relevant.
47.
In the management of diabetic foot ulcers, why might systemic antibiotics alone be insufficient?
a)
They are too expensive
b)
They can cause allergic reactions
c)
They may not reach the wound site effectively ischemia (no blood supply)
d)
They require frequent administration
48.
A Dr is concerned about antimicrobial resistance while using Sorbact for wound care. How do you address this concern?
a)
"Sorbact releases antibiotics to prevent resistance."
b)
"Sorbact does not contribute to antimicrobial resistance."
c)
"Sorbact increases the risk of antimicrobial resistance."
d)
"Sorbact requires additional antimicrobial treatments."
49.
How does nanotechnology enhance the antimicrobial activity of silver in dressings?
a)
By reducing the surface area of silver
b)
By increasing the surface area of silver
c)
By changing the color of silver
d)
By decreasing the amount of silver released
50.
Cutimed Siltec needs to be removed prior to radiotherapy as the dressing may affect the beam path.
a)
True
b)
False
51.
Cutimed Siltec has reliable exudate management and good retention - even under compression
a)
True
b)
False
52.
Can Sorbact replace systemic antibiotic treatment?
a)
Of course, it kills bacteria on the wound surface and within the surrounding tissue. [False]
b)
Sorbact might reduce the consumption of systemic antibiotics because it decreases the bacterial load and by this the risk of infection. But it is not replacing systemic antibiotics. [Correct]
c)
The oral consumption of Sorbact replaces systemic antibiotics. [False]
d)
The oral consumption of Sorbact replaces systemic antibiotics. [False]
53.
What is the benefit of debridement?
a)
Permanent biofilm removal
b)
Temporary disruption of biofilm
c)
Hydration
d)
Barrier cream
54.
Which Sorbact property prevents resistance?
a)
Releases antiseptics
b)
No active substance release
c)
Contains silver
d)
Promotes antibiotics
55.
What is the role of Gatekeeper?
a)
Makes decision
b)
Controls access
c)
Advocates internally
d)
Uses product
56.
Key risk for DFU patients?
a)
Osteomyelitis
b)
Malnutrition
c)
Hypertension
d)
Heart failure
57.
Main advantage of Sorbact over antiseptic dressings?
a)
Cytotoxic effect
b)
Prolonged treatment without cytotoxicity
c)
Higher cost
d)
Color change
58.
Which property makes Sorbact dressings unique?
a)
Releases antibiotics
b)
Physically binds bacteria
c)
Changes wound pH
d)
Provides systemic therapy
59.
What type of study design was used in the research by G. Mosti et al.?
a)
Observational study
b)
Randomised comparative single centre study
c)
Case-control study
d)
Cohort study
60.
Which of the following is NOT listed as a clinical sign of infection in DFU?
a)
Local swelling
b)
Erythema
c)
Dizziness
d)
Purulent discharge
100 %
